KLK3 and Familial prostate cancer: The net result of these actions is down-regulation of AR function, as demonstrated by slowed cell cycle progression and down-regulation of endogenous PSA (prostate specific antigen) expression, an AR target gene utilized clinically to monitor prostate cancer growth and recurrence [98].